
Ginkgo Bioworks Holdings, Inc.
DNAHealthcare|Biotechnology|US
$11.29
+1.33 (+13.35%)
Tangible Book / Share
$5.52
Cash / Share
$4.46
Next Earnings Report
Feb 25, 2027
EPS est. -$1.04 · Revenue est. $23.8M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo
Nov 5, 2026 · Business Wire
Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™
Oct 21, 2026 · GlobeNewsWire
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
Oct 8, 2026 · Business Wire
Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
Oct 8, 2026 · PRNewsWire
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Sep 24, 2026 · GlobeNewsWire
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
Sep 16, 2026 · Business Wire
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
Sep 10, 2026 · Business Wire
DNA X, Inc. Reports Second Quarter 2026 Financial Results
Aug 19, 2026 · GlobeNewsWire
SEC Filings (51)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Oct 29, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 5, 2026 | 8-K | Material event | DocumentIndex |
| Jul 30, 2026 | 8-K | Material event | DocumentIndex |
| Jul 30, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 29, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 7, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 27, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Feb 26, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 26, 2026 | 8-K | Material event | DocumentIndex |
| Feb 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 23, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Sep 4, 2025 | 8-K | Material event | DocumentIndex |
| Sep 4, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | EFFECT | DocumentIndex | |
| Aug 7, 2025 | S-3 | Shelf registration | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Jul 29, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 17, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 13, 2025 | 8-K | Material event | DocumentIndex |
| May 21, 2025 | 8-K | Material event | DocumentIndex |
| May 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 6, 2025 | 8-K | Material event | DocumentIndex |
| Apr 29, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 29, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |